Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

TWST

Twist Bioscience Corp

Nov 21 • 04:00PM ET

28.56

+2.49 9.55 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN PACB CRSP EDIT NTLA BEAM SGMO AMGN REGN BIIB

| Held by: ARKK VTI ARKG XBI VB IWM VBK VXF IWO IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.31	Insider Own	4.77%	Shs Outstand	60.63M	Perf Week	6.29%
Market Cap	1.75B	Forward P/E	-	EPS next Y	-1.06	Insider Trans	-6.87%	Shs Float	58.23M	Perf Month	-10.27%
Enterprise Value	1.59B	PEG	-	EPS next Q	-0.43	Inst Own	116.83%	Short Float	18.11%	Perf Quarter	4.27%
Income	-77.67M	P/S	4.64	EPS this Y	-14.75%	Inst Trans	2.07%	Short Ratio	6.09	Perf Half Y	1.06%
Sales	376.57M	P/B	3.66	EPS next Y	28.98%	ROA	-12.37%	Short Interest	10.55M	Perf YTD	-38.54%
Book/sh	7.80	P/C	7.51	EPS next 5Y	26.66%	ROE	-16.43%	52W High	55.33 -48.38%	Perf Year	-30.88%
Cash/sh	3.80	P/FCF	-	EPS past 3/5Y	31.51% 18.31%	ROIC	-14.53%	52W Low	23.30 22.58%	Perf 3Y	0.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.76% 33.11%	Gross Margin	50.72%	Volatility	8.88% 7.40%	Perf 5Y	-72.55%
Dividend TTM	-	EV/Sales	4.22	EPS Y/Y TTM	63.81%	Oper. Margin	-36.18%	ATR (14)	2.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.33	Sales Y/Y TTM	20.32%	Profit Margin	-20.63%	RSI (14)	47.06	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	3.64	EPS Q/Q	24.11%	SMA20	-5.04%	Beta	2.28	Target Price	36.44
Payout	-	Debt/Eq	0.16	Sales Q/Q	16.88%	SMA50	-4.36%	Rel Volume	1.50	Prev Close	26.07
Employees	979	LT Debt/Eq	0.13	Earnings	Nov 14 BMO	SMA200	-15.61%	Avg Volume	1.73M	Price	28.56
IPO	Oct 31, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-8.36% 1.73%	Trades		Volume	2,607,765	Change	9.55%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-04-25	Initiated	Stephens	Overweight	$41
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Jun-04-24	Initiated	Guggenheim	Buy	$53
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

Nov-18-25 09:40AM	Company News for Nov 18, 2025 (Zacks)
04:45AM	Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT (Insider Monkey)
Nov-17-25 10:13AM	Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? (Insider Monkey)
Nov-14-25 02:01PM	Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -10.13%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:34AM	Loading…
07:34AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-13-25 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -6.18%
Nov-12-25 08:10AM	Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:20PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 09:11AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More (24/7 Wall St.)
08:00AM	Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference (Business Wire)
Nov-03-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-24-25 06:20AM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire) +7.16%
Oct-23-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 (Business Wire)
08:53AM	Loading…
Oct-22-25 08:53AM	Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 (Insider Monkey) -6.98%
Oct-06-25 08:00AM	Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System (Business Wire)
Oct-02-25 02:00PM	Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design (Business Wire)
Sep-24-25 04:47AM	Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience (Zacks)
Sep-23-25 09:23AM	5 Biotech Stocks Worth Adding to Your Portfolio Now (Zacks)
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
Sep-17-25 02:18PM	TD Cowen Reaffirms Buy on Twist Bioscience (TWST) Amid Scaling and Margin Gains (Insider Monkey)
Sep-03-25 08:00AM	Twist Bioscience to Present at Baird 2025 Global Healthcare Conference (Business Wire)
Sep-02-25 08:00AM	Twist Bioscience Collaborates with Synthetic Design Lab (Business Wire)
Aug-19-25 08:00AM	Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution (Business Wire)
Aug-13-25 07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-07-25 09:35AM	After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) (Zacks)
Aug-06-25 08:00AM	Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors (Business Wire) -5.89%
Aug-05-25 03:08AM	Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.90%
Aug-04-25 08:25AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -10.30%
07:24AM	Loading…
07:24AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results (Business Wire)
Jul-31-25 08:00AM	Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model (Business Wire)
Jul-28-25 08:24AM	Is Twist Bioscience Corp. (TWST) Nearing Profitability? (Insider Monkey)
Jul-24-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jul-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 (Business Wire)
Jul-07-25 08:00AM	Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format (Business Wire) -6.76%
Jun-23-25 01:40AM	Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions (Insider Monkey)
May-22-25 08:00AM	Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions (Business Wire)
May-15-25 08:00AM	Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference (Business Wire)
May-13-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-08-25 11:43PM	Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) -5.49%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 03:02AM	Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.85%
01:18AM	Q2 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
May-05-25 11:41AM	Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript (Seeking Alpha) -8.44%
08:25AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results (Business Wire)
07:10AM	Twist Bioscience Spins Out DNA Data Storage as Independent Company (Business Wire)
May-02-25 09:23AM	What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings (GuruFocus.com)
May-01-25 02:06PM	Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (Seeking Alpha)
12:05PM	Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers (Seeking Alpha)
Apr-24-25 08:00AM	Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System (Business Wire) +6.78%
Apr-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 (Business Wire)
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks)
08:00AM	Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics (Business Wire)
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
Mar-20-25 04:58PM	Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy (InsiderMonkey)
Mar-12-25 12:12PM	Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? (Zacks)
Mar-11-25 07:30AM	Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost (Business Wire) +6.59%
Mar-01-25 02:38PM	Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? (Insider Monkey)
Feb-25-25 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-19-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-06-25 04:58PM	Twist Bioscience Corporation (TWST): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
12:00PM	Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-04-25 02:01AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:47AM	Q1 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-03-25 08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results (Business Wire)
Jan-31-25 07:05AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Jan-22-25 08:00AM	Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 (Business Wire)
Dec-27-24 12:00PM	All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy (Zacks)
Dec-23-24 08:48AM	Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains? (Zacks)
Dec-19-24 08:00AM	Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-16-24 09:55AM	Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Dec-11-24 11:59AM	Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey) -5.24%
Nov-27-24 07:30AM	Twist Bioscience named a Best Idea for 2025 at TD Cowen (TipRanks)
Nov-20-24 09:15AM	AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care (PR Newswire)
Nov-19-24 09:15PM	Twist Bioscience price target lowered to $52 from $55 at Barclays (TipRanks)
06:49PM	Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
02:33AM	Q4 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
02:02AM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Nov-18-24 12:17PM	Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps (Benzinga) +12.31%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:33AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-15-24 10:44PM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.31%
Nov-14-24 08:00AM	Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference (Business Wire) -8.31%
Nov-07-24 04:05PM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-31-24 08:00AM	Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI (GlobeNewswire) -6.53%
Oct-30-24 08:00AM	Twist Bioscience Launches FlexPrep Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics (Business Wire)
Oct-24-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 (Business Wire)
Oct-22-24 08:00AM	Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash (Business Wire)
Oct-15-24 08:00AM	Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer (Business Wire)
Sep-12-24 08:00AM	Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance (Business Wire)
Sep-09-24 08:00AM	Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels (Business Wire)
Sep-08-24 03:55PM	Twist Bioscience Corporation (TWST): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WERNER ROBERT F.	Officer	Nov 21 '25	Proposed Sale	26.50	229	6,069		Nov 21 03:36 PM
Leproust Emily M.	Officer	Nov 21 '25	Proposed Sale	26.50	2,663	70,579		Nov 21 03:30 PM
Laponis Adam	Officer	Nov 21 '25	Proposed Sale	26.50	887	23,509		Nov 21 03:24 PM
Green Paula	Officer	Nov 21 '25	Proposed Sale	26.50	598	15,849		Nov 21 03:19 PM
Finn Patrick John	Officer	Nov 21 '25	Proposed Sale	26.50	1,776	47,070		Nov 21 03:18 PM
Cho Dennis	Officer	Nov 21 '25	Proposed Sale	26.50	757	20,063		Nov 21 03:14 PM
JOHANNESSEN JAN	Director	Nov 18 '25	Sale	24.77	7,044	174,480	14,859	Nov 20 04:05 PM
JOHANNESSEN JAN	Director	Nov 18 '25	Proposed Sale	24.77	7,044	174,480		Nov 18 11:54 AM
Cho Dennis	See Remarks	Nov 03 '25	Sale	32.08	1,019	32,689	120,694	Nov 05 04:05 PM
Finn Patrick John	President and COO	Nov 03 '25	Sale	32.08	2,755	88,379	265,919	Nov 05 04:05 PM
Green Paula	SVP of Human Resources	Nov 03 '25	Sale	32.08	1,084	34,774	142,187	Nov 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Nov 03 '25	Sale	32.08	4,887	156,772	733,922	Nov 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 03 '25	Sale	32.08	160	5,133	50,870	Nov 05 04:05 PM
Cho Dennis	See Remarks	Oct 30 '25	Sale	31.44	6,515	204,860	121,713	Nov 03 04:05 PM
Finn Patrick John	President and COO	Oct 30 '25	Sale	31.44	17,606	553,608	268,674	Nov 03 04:05 PM
Green Paula	SVP of Human Resources	Oct 30 '25	Sale	31.44	6,920	217,595	143,271	Nov 03 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 30 '25	Sale	31.44	31,379	986,691	738,809	Nov 03 04:05 PM
Laponis Adam	Chief Financial Officer	Oct 30 '25	Sale	31.44	5,517	173,478	111,008	Nov 03 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Oct 30 '25	Sale	31.44	1,016	31,947	51,030	Nov 03 04:05 PM
WERNER ROBERT F.	Officer	Nov 03 '25	Proposed Sale	32.08	160	5,133		Nov 03 03:23 PM
Green Paula	Officer	Nov 03 '25	Proposed Sale	32.08	1,084	34,774		Nov 03 03:21 PM
Finn Patrick John	Officer	Nov 03 '25	Proposed Sale	32.08	2,755	88,379		Nov 03 03:19 PM
Leproust Emily M.	Officer	Nov 03 '25	Proposed Sale	32.08	4,887	156,772		Nov 03 03:18 PM
Cho Dennis	Officer	Nov 03 '25	Proposed Sale	32.08	1,019	32,689		Nov 03 03:12 PM
WERNER ROBERT F.	Officer	Oct 30 '25	Proposed Sale	31.44	1,016	31,947		Oct 30 04:00 PM
Cho Dennis	Officer	Oct 30 '25	Proposed Sale	31.44	6,515	204,860		Oct 30 03:52 PM
Leproust Emily M.	Officer	Oct 30 '25	Proposed Sale	31.44	31,379	986,691		Oct 30 03:50 PM
Finn Patrick John	Officer	Oct 30 '25	Proposed Sale	31.44	17,606	553,608		Oct 30 03:46 PM
Green Paula	Officer	Oct 30 '25	Proposed Sale	31.44	6,920	217,595		Oct 30 03:46 PM
Laponis Adam	Officer	Oct 30 '25	Proposed Sale	31.44	5,517	173,478		Oct 30 03:43 PM
Finn Patrick John	President and COO	Oct 23 '25	Sale	30.88	2,240	69,160	206,495	Oct 27 04:05 PM
Finn Patrick John	Officer	Oct 23 '25	Proposed Sale	30.87	2,240	69,160		Oct 23 03:13 PM
Laponis Adam	Chief Financial Officer	Oct 08 '25	Sale	31.15	3,000	93,450	94,042	Oct 10 04:05 PM
Laponis Adam	Chief Financial Officer	Oct 09 '25	Sale	32.92	2,517	82,865	91,525	Oct 10 04:05 PM
Laponis Adam	Officer	Oct 09 '25	Proposed Sale	32.92	2,517	82,864		Oct 09 03:13 PM
Laponis Adam	Chief Financial Officer	Oct 06 '25	Sale	32.19	5,875	189,099	97,042	Oct 08 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 06 '25	Sale	32.19	31,348	1,008,998	601,212	Oct 08 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Oct 06 '25	Sale	32.19	2,041	65,694	46,413	Oct 08 04:05 PM
Green Paula	SVP of Human Resources	Oct 06 '25	Sale	32.19	9,724	312,986	114,678	Oct 08 04:05 PM
Finn Patrick John	President and COO	Oct 06 '25	Sale	32.19	23,747	764,345	208,735	Oct 08 04:05 PM
Cho Dennis	See Remarks	Oct 06 '25	Sale	32.19	3,876	124,757	98,710	Oct 08 04:05 PM
Laponis Adam	Officer	Oct 08 '25	Proposed Sale	31.15	3,000	93,450		Oct 08 09:50 AM
Laponis Adam	Officer	Oct 06 '25	Proposed Sale	32.19	5,875	189,099		Oct 06 05:18 PM
Leproust Emily M.	Officer	Oct 06 '25	Proposed Sale	32.19	31,348	1,008,998		Oct 06 05:15 PM
WERNER ROBERT F.	Officer	Oct 06 '25	Proposed Sale	32.19	2,041	65,694		Oct 06 05:09 PM
Finn Patrick John	Officer	Oct 06 '25	Proposed Sale	32.19	23,747	764,345		Oct 06 04:52 PM
Green Paula	Officer	Oct 06 '25	Proposed Sale	32.19	9,724	312,986		Oct 06 04:41 PM
Cho Dennis	Officer	Oct 06 '25	Proposed Sale	32.19	3,876	124,757		Oct 06 04:41 PM
Cho Dennis	See Remarks	Oct 02 '25	Sale	29.16	124	3,616	102,586	Oct 06 04:05 PM
Green Paula	SVP of Human Resources	Oct 02 '25	Sale	29.16	140	4,083	124,402	Oct 06 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 02 '25	Sale	29.16	476	13,881	632,560	Oct 06 04:05 PM
Finn Patrick John	President and COO	Oct 02 '25	Sale	29.16	206	6,007	232,482	Oct 06 04:05 PM
Green Paula	Officer	Oct 02 '25	Proposed Sale	29.16	140	4,083		Oct 02 04:33 PM
Cho Dennis	Officer	Oct 02 '25	Proposed Sale	29.16	124	3,616		Oct 02 03:49 PM
Finn Patrick John	Officer	Oct 02 '25	Proposed Sale	29.16	206	6,007		Oct 02 03:35 PM
Leproust Emily M.	Officer	Oct 02 '25	Proposed Sale	29.16	476	13,881		Oct 02 03:21 PM
Cho Dennis	See Remarks	Sep 22 '25	Sale	27.56	233	6,421	102,710	Sep 24 04:07 PM
Green Paula	SVP of Human Resources	Sep 22 '25	Sale	27.56	295	8,130	124,542	Sep 24 04:07 PM
Leproust Emily M.	Chief Executive Officer	Sep 22 '25	Sale	27.56	1,704	46,962	633,036	Sep 24 04:07 PM
Leproust Emily M.	Officer	Sep 22 '25	Proposed Sale	27.56	1,704	46,962		Sep 22 03:17 PM
Green Paula	Officer	Sep 22 '25	Proposed Sale	27.56	295	8,130		Sep 22 03:14 PM
Cho Dennis	Officer	Sep 22 '25	Proposed Sale	27.56	233	6,421		Sep 22 03:13 PM
Cho Dennis	See Remarks	Sep 15 '25	Sale	25.33	94	2,381	102,943	Sep 17 09:38 AM
Cho Dennis	Officer	Sep 15 '25	Proposed Sale	25.33	94	2,381		Sep 15 03:17 PM
Cho Dennis	See Remarks	Sep 08 '25	Sale	25.76	269	6,929	103,037	Sep 10 09:13 AM
Green Paula	SVP of Human Resources	Sep 08 '25	Sale	25.76	892	22,978	124,837	Sep 10 09:13 AM
Leproust Emily M.	Chief Executive Officer	Sep 08 '25	Sale	25.76	2,265	58,346	634,740	Sep 10 09:12 AM
WERNER ROBERT F.	Chief Accounting Officer	Sep 08 '25	Sale	25.76	235	6,054	48,454	Sep 10 09:11 AM
Cho Dennis	Officer	Sep 08 '25	Proposed Sale	25.76	269	6,929		Sep 08 03:32 PM
Leproust Emily M.	Officer	Sep 08 '25	Proposed Sale	25.76	2,265	58,346		Sep 08 03:27 PM
WERNER ROBERT F.	Officer	Sep 08 '25	Proposed Sale	25.76	235	6,054		Sep 08 03:24 PM
Green Paula	Officer	Sep 08 '25	Proposed Sale	25.76	892	22,978		Sep 08 03:18 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 25 '25	Sale	27.69	853	23,620	48,689	Aug 27 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 21 '25	Sale	25.96	2,716	70,518	637,005	Aug 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 21 '25	Sale	25.96	238	6,179	49,542	Aug 25 04:05 PM
Green Paula	SVP of Human Resources	Aug 21 '25	Sale	25.96	619	16,072	125,729	Aug 25 04:05 PM
Laponis Adam	Chief Financial Officer	Aug 21 '25	Sale	25.96	918	23,835	102,917	Aug 25 04:05 PM
Finn Patrick John	President and COO	Aug 21 '25	Sale	25.96	1,840	47,774	233,529	Aug 25 04:05 PM
Cho Dennis	See Remarks	Aug 21 '25	Sale	25.96	521	13,527	103,306	Aug 25 04:05 PM
WERNER ROBERT F.	Officer	Aug 25 '25	Proposed Sale	27.69	853	23,621		Aug 25 03:20 PM
Leproust Emily M.	Officer	Aug 21 '25	Proposed Sale	25.96	2,716	70,519		Aug 21 03:25 PM
Finn Patrick John	Officer	Aug 21 '25	Proposed Sale	25.96	1,840	47,774		Aug 21 03:19 PM
Green Paula	Officer	Aug 21 '25	Proposed Sale	25.96	619	16,072		Aug 21 03:17 PM
Laponis Adam	Officer	Aug 21 '25	Proposed Sale	25.96	918	23,835		Aug 21 03:16 PM
WERNER ROBERT F.	Officer	Aug 21 '25	Proposed Sale	25.96	238	6,179		Aug 21 03:16 PM
Cho Dennis	Officer	Aug 21 '25	Proposed Sale	25.96	521	13,527		Aug 21 03:10 PM
WERNER ROBERT F.	Chief Accounting Officer	Aug 04 '25	Sale	28.36	186	5,276	49,780	Aug 06 04:05 PM
Leproust Emily M.	Chief Executive Officer	Aug 04 '25	Sale	28.36	5,585	158,413	639,721	Aug 06 04:05 PM
Green Paula	SVP of Human Resources	Aug 04 '25	Sale	28.36	1,255	35,597	126,206	Aug 06 04:05 PM
Cho Dennis	See Remarks	Aug 04 '25	Sale	28.36	785	22,266	103,827	Aug 06 04:05 PM
Finn Patrick John	President and COO	Aug 04 '25	Sale	28.36	3,189	90,453	235,153	Aug 06 04:05 PM
WERNER ROBERT F.	Officer	Aug 04 '25	Proposed Sale	28.36	186	5,276		Aug 04 04:21 PM
Leproust Emily M.	Officer	Aug 04 '25	Proposed Sale	28.36	5,585	158,414		Aug 04 04:14 PM
Green Paula	Officer	Aug 04 '25	Proposed Sale	28.36	1,255	35,597		Aug 04 04:03 PM
Finn Patrick John	Officer	Aug 04 '25	Proposed Sale	28.36	3,189	90,453		Aug 04 03:56 PM
Cho Dennis	Officer	Aug 04 '25	Proposed Sale	28.36	785	22,266		Aug 04 03:35 PM
Finn Patrick John	President and COO	Jul 23 '25	Sale	35.74	2,232	79,774	238,342	Jul 25 04:05 PM
Finn Patrick John	Officer	Jul 23 '25	Proposed Sale	35.74	2,232	79,773		Jul 23 03:12 PM
Laponis Adam	Chief Financial Officer	Jul 09 '25	Sale	38.15	2,449	93,420	103,569	Jul 11 04:05 PM
Laponis Adam	Officer	Jul 09 '25	Proposed Sale	38.15	2,449	93,419		Jul 09 03:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

TWST

Twist Bioscience Corp

Upgrade your FINVIZ experience